Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
02/2010
02/09/2010US7658947 includes an aqueous base of water, methylcellulose and citric acid, pharmaceutically active or cosmetic agent or nutritional agent; drug delivery for treating cardiovascular and psychological disorders, vision defects, inflammation, infections and for cartilage repair and birth control
02/09/2010US7658941 Warming and nonirritating lubricant compositions and method of comparing irritation
02/09/2010US7658939 Inert core, first layer comprising naltrexone, nalmefene or salts; and second hydrophobic layer; pain treatment
02/09/2010US7658938 Containing active drug; bioavailability; sustained release; containing fatty acid or ester
02/09/2010US7658932 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome
02/09/2010US7658914 first container containing a dry formulation of polyoxyethylene glycol , ascorbic acid and sodium sulfate, calcium sulfate and sodium chloride, potassium chloride, second container containing dry ascorbic acid or sodium or potassium salt; also contains flavor, sweetener; for colonoscopy preperation
02/09/2010CA2625906C Lazaroids-based compositions and methods for preventing adhesion formation using the same
02/09/2010CA2533906C Chewable capsule and production method thereof
02/09/2010CA2530788C Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
02/09/2010CA2485977C Short chain polymer for enhancing the bioadhesiveness of polymers on mucosal membrane
02/09/2010CA2483597C New pharmaceutical compositions containing flibanserin polymorph a
02/09/2010CA2473394C Semi-fluorinated alkanes and their use
02/09/2010CA2466720C Medicament for the treatment of viral skin and tumour diseases
02/09/2010CA2445638C Semi-solid delivery vehicle and pharmaceutical compositions
02/09/2010CA2440588C Chronotherapeutic dosage forms
02/09/2010CA2431367C Solution for removing cataracts via liquefracture
02/09/2010CA2431079C Method and composition for the treatment of diabetic neuropathy
02/09/2010CA2418224C Pharmaceutical composition
02/09/2010CA2403670C Multiparticulate drug form comprising at least two differently coated pellet forms
02/09/2010CA2389688C A method of microencapsulation
02/09/2010CA2378431C Peptides that lower blood glucose levels
02/09/2010CA2370714C Bacterial ghosts as carrier and targeting vehicles
02/09/2010CA2353612C Boron neutron capture therapy using pre-targeting methods
02/09/2010CA2338546C Particle-forming compositions containing fused pyrrolocarbazoles
02/09/2010CA2330925C Pharmaceutical formulations for igf/igfbp
02/09/2010CA2294274C Compositions and methods for reversibly increasing permeability of biomembranes
02/09/2010CA2287469C Interactive system for presenting and eliminating substances
02/09/2010CA2218369C Transdermal electrotransport delivery of fentanyl and sufentanil
02/09/2010CA2205910C Plasmids suitable for il-2 expression
02/06/2010CA2660507A1 Targeted nanoparticles for cancer diagnosis and treatment
02/04/2010WO2010014874A2 Peptide-polymer conjugates
02/04/2010WO2010014708A2 Factor viii polymer conjugates
02/04/2010WO2010014689A1 Pharmaceutical formulations comprising elastin-like proteins
02/04/2010WO2010014258A2 Conjugates having a releasable linkage
02/04/2010WO2010014176A2 Preparation method of biodegradable micro-particles containing drugs
02/04/2010WO2010014172A2 Delivery particle
02/04/2010WO2010014117A1 Drug carriers
02/04/2010WO2010014081A1 Particle compositions with a pre-selected cell internalization mode
02/04/2010WO2010013836A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
02/04/2010WO2010013815A1 Composition for inhibiting expression of target gene
02/04/2010WO2010013762A1 Metastin derivative and use thereof
02/04/2010WO2010013656A1 Packaging material
02/04/2010WO2010013601A1 Microneedle device and method for increasing the response of japanese encephalitis virus antigen with the microneedle device
02/04/2010WO2010013555A1 Novel lipid dipeptide and gel
02/04/2010WO2010013551A1 Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside
02/04/2010WO2010013350A1 S/o type transdermal immunizing agent
02/04/2010WO2010013279A2 Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug
02/04/2010WO2010013137A1 Active particles for bio-analytical applications and methods for preparation thereof
02/04/2010WO2010013136A2 Active particles for bio-analytical applications and methods for their preparation
02/04/2010WO2010012940A2 Microparticulate oral drug form useful for the modified release of nanoparticles
02/04/2010WO2010012850A1 Cell-penetrating peptides and uses
02/04/2010WO2010012751A2 Sesame seed derived pigments
02/04/2010WO2009151590A3 Methods of treating cyp2d6 alternative metabolizers
02/04/2010WO2009150257A3 Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
02/04/2010WO2009137611A9 Treatment of pulmonary fungal infection with voriconazole via inhalation
02/04/2010WO2009129511A4 Fluocinolone formulations in a biodegradable polymer carrier
02/04/2010WO2009117242A3 Aqueous pharmaceutical compositions containing borate-polyol complexes
02/04/2010WO2009016180A3 Peptide imaging agents
02/04/2010WO2009010494A3 Micro-particles, blood-substitute and method for forming same
02/04/2010US20100029922 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes
02/04/2010US20100029906 Synthetic mimics of mammalian cell surface receptors: method and compositions
02/04/2010US20100029790 Solid film, rapidly dissolvable in liquids
02/04/2010US20100029789 Photocrosslinked combination of reactive hyaluronan (e.g., reacted with glycidyl methacrylate) and a hydrophillic polymer or a monomer, particularly an acrylamide derivative; orthopedic implants and spinal disc substitutes
02/04/2010US20100029788 Wet edible pearlescent film coatings
02/04/2010US20100029786 Flavor improving agent, and food and drink containing the same
02/04/2010US20100029785 Particle compositions with a pre-selected cell internalization mode
02/04/2010US20100029783 Stabilized compositions of alkylating agents and methods of using same
02/04/2010US20100029780 Topical composition
02/04/2010US20100029747 Methods and compositions for inhibiting the function of polynucleotide sequences
02/04/2010US20100029667 Spray dried formulation
02/04/2010US20100029549 Situ self-setting mineral-polymer hybrid materials, composition and use thereof
02/04/2010US20100029545 Boronic acid-containing block copolymers for controlled drug delivery
02/04/2010US20100029544 Composition
02/04/2010US20100028452 Delivery system for active components as part of an edible composition having preselected tensile strength
02/04/2010US20100028445 Polymer
02/04/2010US20100028438 Hyaluronic Acid-Based Gels Including Lidocaine
02/04/2010US20100028434 Temperature controlled and pH dependent self gelling biopolymeric aqueous solution
02/04/2010US20100028431 Compositions and methods for therapeutic use
02/04/2010US20100028421 Solid Oral Dosage Form Containing an Enhancer
02/04/2010US20100028407 Layered bio-adhesive compositions and uses thereof
02/04/2010US20100028399 Use of Polymers
02/04/2010US20100028391 Cosmetics Comprising A Modified Organopolysiloxane
02/04/2010US20100028383 Chemically defined stabiliser
02/04/2010US20100028320 Methods and Compositions for Inhibiting Diseases of the Central Nervous System
02/04/2010US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents
02/04/2010US20100028260 Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
02/04/2010US20100026235 Charging Control in an Electric Vehicle
02/04/2010CA2732635A1 Curcumin nanoparticles and methods of producing the same
02/04/2010CA2732252A1 Particle compositions with a pre-selected cell internalization mode
02/04/2010CA2732243A1 Pharmaceutical composition
02/04/2010CA2731449A1 Microparticulate oral drug form useful for the modified release of nanoparticles
02/04/2010CA2731173A1 Nanoparticle compositions for nucleic acids delivery system
02/04/2010CA2730714A1 Factor viii polymer conjugates
02/04/2010CA2730441A1 Delivery particle
02/04/2010CA2718750A1 Preparation method of biodegradable micro-particles containing drugs
02/04/2010CA2674116A1 Solid film, rapidly dissolvable in liquids
02/03/2010EP2149381A2 Method of treating malignancies through induction of blood immune responses
02/03/2010EP2149376A1 Body-temperature lowering depressant
02/03/2010EP2148708A1 Composition for enhancing bone formation
02/03/2010EP2148700A2 Compositions and particles containing cellulosic fibers and stabilized- and/or activated- urease inhibitors, as well as methods of making and using the same
1 ... 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 ... 1712